Farlan Veraitch

Farlan Singh Veraitch is the Co-Founder and Chief Scientific Officer at Ori Biotech, a company specializing in cell and gene therapy (CGT) manufacturing technology.15 He is an internationally recognized expert in CGT manufacturing with a wealth of experience in the field.1

Background and Expertise

Farlan Veraitch has over 15 years of experience as a leading academic at University College London, where he pioneered innovative technologies in CGT bioprocessing.1 His extensive background in academia has provided him with a strong foundation for his current role at Ori Biotech.

Role at Ori Biotech

As the Chief Scientific Officer at Ori Biotech, Farlan leads the research and development of the company's revolutionary manufacturing technology platforms.1 His work is focused on dramatically reducing the cost of CGTs and enabling widespread patient access to these life-changing therapies.1

Achievements and Recognition

Farlan's contributions to the field have not gone unnoticed. In 2021, he was named as one of the ELITE 100 in Entrepreneurship by PM360, recognizing his impact in the industry.4

Recent Activities

Farlan has been actively involved in the development and deployment of Ori Biotech's technology:

• In August 2024, he announced that their technology was being used by pharmaceutical companies, CDMOs, and academic medical centers to deliver faster results.2
• In May 2024, he was in Vancouver to reveal his first commercial product to the cell therapy community.3

Farlan Singh Veraitch continues to play a crucial role in advancing CGT manufacturing technology, working towards making these therapies more accessible and affordable for patients worldwide.